Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5845621 | Pulmonary Pharmacology & Therapeutics | 2015 | 7 Pages |
Abstract
Corticosteroids are frequently prescribed anti-inflammatory medications. Inhaled corticosteroids (ICS) are indicated for Chronic Obstructive Pulmonary Disease (COPD) and asthma. ICS are associated with a decrease in exacerbations and improved quality of life in COPD, however multiple studies have linked the chronic use of ICSs with an increased risk of developing pneumonia, though the effect on mortality is unclear. We review the association of ICS with the risk of pneumonia and the implications on clinical outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Oriol Sibila, Natalia Soto-Gomez, Marcos I. Restrepo,